Original Research
Published on 01 Oct 2024
Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study
in Cancer Immunity and Immunotherapy
- 685 views
Original Research
Published on 01 Oct 2024
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 01 Oct 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 30 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 27 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 27 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 27 Sep 2024
in Cancer Immunity and Immunotherapy
Review
Published on 27 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 27 Sep 2024
in Cancer Immunity and Immunotherapy